These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of infections caused by resistant Staphylococcus aureus. Anstead GM; Quinones-Nazario G; Lewis JS Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681 [TBL] [Abstract][Full Text] [Related]
6. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
7. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial agents in treatment of MRSA infections. Johnson MD; Decker CF Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282 [No Abstract] [Full Text] [Related]
11. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Marcinak JF; Frank AL Curr Opin Infect Dis; 2003 Jun; 16(3):265-9. PubMed ID: 12821819 [TBL] [Abstract][Full Text] [Related]
12. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs. Sabol KE; Echevarria KL; Lewis JS Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661 [TBL] [Abstract][Full Text] [Related]
13. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy? Wunderink RG Infect Dis Clin North Am; 2013 Mar; 27(1):177-88. PubMed ID: 23398873 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Maclayton DO; Hall RG Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012 [TBL] [Abstract][Full Text] [Related]
15. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus. Arnold FW; Wojda B J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650 [TBL] [Abstract][Full Text] [Related]
16. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections. Johnson JR Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761 [No Abstract] [Full Text] [Related]
17. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis. Fusco NM; Toussaint KA; Prescott WA Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881 [TBL] [Abstract][Full Text] [Related]